Finance

Lists
4892:TYO
Cyfuse Biomedical KK
655,00 JPY
-0,30%
(-2,00) 1D
2 ოქტ, 15:30:00 GMT+9  ·   JPY
All symbols
SymbolPriceChange% Change
Generating top insights for 4892...
Open
652 JPY
High
657 JPY
Low
645 JPY
Mkt. cap
6,61 მლრდ.
Avg. vol.
62,42 ათ.
Volume
46,60 ათ.
52-wk high
764 JPY
52-wk low
487 JPY
EPS
-82 JPY
No. of employees
23
Open
652 JPY
High
657 JPY
Low
645 JPY
Mkt. cap
6,61 მლრდ.
Avg. vol.
62,42 ათ.
Volume
46,60 ათ.
52-wk high
764 JPY
52-wk low
487 JPY
EPS
-82 JPY
No. of employees
23
News stories
From web sources and news partners
Simply Wall Street
Simply Wall Street
·
20 წუთის წინ
IREN (IREN) Dropped, What Is Behind The Latest Attention?
Moomoo
Moomoo
·
1 საათის წინ
Chip-Led Rally Lifts Nasdaq; Tesla Jumps 4.65%
ChartMill
ChartMill
·
18 წუთის წინ
S&P 500 Most Active Stocks in Today's US Session
CNBC
CNBC
·
7 საათის წინ
Friday's rally in the S&P 500 might not be enough, but Linde is out of this world
About Cyfuse Biomedical KK
CEO-
Employees23
Founded11 აგვ. 2010
Headquarters-
SectorHealth care
Websitecyfusebio.com
Previous reportsAll values in JPY
Loading Previous Earnings...
Revenue
Net income
All values in JPY
სექ. 2025
დეკ. 2025
მარ. 2026
ივნ. 2026
Revenue
32,00 მლნ.
169,00 მლნ.
28,00 მლნ.
76,00 მლნ.
Cost of goods sold
21,00 მლნ.
81,00 მლნ.
8,00 მლნ.
31,00 მლნ.
Cost of revenue
21,00 მლნ.
81,00 მლნ.
8,00 მლნ.
31,00 მლნ.
Research and development expenses
-
416,00 მლნ.
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
230,00 მლნ.
-203,00 მლნ.
236,00 მლნ.
246,00 მლნ.
Operating expense
230,00 მლნ.
227,00 მლნ.
236,00 მლნ.
246,00 მლნ.
Total operating expenses
251,00 მლნ.
308,00 მლნ.
244,00 მლნ.
277,00 მლნ.
Operating income
-219,00 მლნ.
-139,00 მლნ.
-216,00 მლნ.
-201,00 მლნ.
Other non operating income
-14,00 მლნ.
20,00 მლნ.
-3,00 მლნ.
-5,00 მლნ.
EBT including unusual items
-235,00 მლნ.
-125,00 მლნ.
-224,00 მლნ.
-209,00 მლნ.
EBT excluding unusual items
-235,00 მლნ.
-125,00 მლნ.
-224,00 მლნ.
-209,00 მლნ.
Income tax expense
-
1,00 მლნ.
-
1,00 მლნ.
Effective tax rate
-
-0,80%
-
-0,48%
Other operating expenses
-
-
-
-
Net income
-235,00 მლნ.
-126,00 მლნ.
-224,00 მლნ.
-210,00 მლნ.
Net profit margin
-734,38%
-74,56%
-800,00%
-276,32%
Earnings per share
-
-
-
-
Interest and investment income
2,00 მლნ.
-
1,00 მლნ.
2,00 მლნ.
Interest expense
-4,00 მლნ.
-6,00 მლნ.
-6,00 მლნ.
-5,00 მლნ.
Net interest expenses
-2,00 მლნ.
-6,00 მლნ.
-5,00 მლნ.
-3,00 მლნ.
Depreciation and amortization charges
-
14,00 მლნ.
-
-
EBITDA
-209,50 მლნ.
-129,75 მლნ.
-206,75 მლნ.
-194,50 მლნ.
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google აპები